1Maritim, AC, Sanders, RA & Watkins, JB (2003) Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17, 24–38.
2Kakkar, R, Mantha, SV, Radhi, J, et al. (1998) Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin Sci 94, 623–632.
3Tolman, KG, Fonseca, V, Dalpiaz, A, et al. (2007) Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care 30, 734–743.
4Rutter, GA (2000) Diabetes: the importance of the liver. Curr Biol 10, R736–R738.
5Evelson, P, Susemihl, C, Villarreal, I, et al. (2005) Hepatic morphological changes and oxidative stress in chronic streptozotocin-diabetic rats. Ann Hepatol 4, 115–120.
6Guven, A, Yavuz, O, Cam, M, et al. (2006) Effects of melatonin on streptozotocin-induced diabetic liver injury in rats. Acta Histochem 108, 85–93.
7Parker, GJ, Lund, KC, Taylor, RP, et al. (2003) Insulin resistance of glycogen synthase mediated by O-linked N-acetylglucosamine. J Biol Chem 278, 10022–10027.
8Yang, X, Su, K, Roos, MD, et al. (2001) O-Linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci U S A 98, 6611–6616.
9Gao, Y, Miyazaki, J & Hart, GW (2003) The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells. Arch Biochem Biophys 415, 155–163.
10Juang, YT, Solomou, EE, Rellahan, B, et al. (2002) Phosphorylation and O-linked glycosylation of Elf-1 leads to its translocation to the nucleus and binding to the promoter of the TCR zeta-chain. J Immunol 168, 2865–2871.
11Zachara, NE & Hart, GW (2004) O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 1673, 13–28.
12Karunakaran, U & Jeoung, NH (2010) O-GlcNAc modification: friend or foe in diabetic cardiovascular disease. Korean Diabetes J 34, 211–219.
13Reber, L, Vermeulen, L, Haegeman, G, et al. (2009) Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation. PLoS One 4, e4393.
14Piwien-Pilipuk, G, MacDougald, O & Schwartz, J (2002) Dual regulation of phosphorylation and dephosphorylation of C/EBPbeta modulate its transcriptional activation and DNA binding in response to growth hormone. J Biol Chem 277, 44557–44565.
15Dhakshinamoorthy, S, Long, DJ & Jaiswal, AK (2000) Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. Curr Top Cell Regul 36, 201–216.
16Miao, L & St Clair, DK (2009) Regulation of superoxide dismutase genes: implications in diseases. Free Radic Biol Med 47, 344–356.
17Nozik-Grayck, E, Suliman, HB & Piantadosi, CA (2005) Extracellular superoxide dismutase. Int J Biochem Cell B 37, 2466–2471.
18Moini, H, Packer, L & Saris, NEL (2002) Antioxidant and prooxidant activities of α-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharm 182, 84–90.
19Packer, L, Kraemer, K & Rimbach, G (2001) Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17, 888–895.
20Petersen Shay, K, Moreau, RF, Smith, EJ, et al. (2009) Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 1790, 1149–1160.
21Sadi, G & Güray, T (2009) Gene expressions of Mn-SOD and GPx-1 in streptozotocin-induced diabetes: effect of antioxidants. Mol Cell Biochem 327, 127–134.
22Rossini, AA, Like, AA, Chick, WL, et al. (1977) Studies of streptozotocin-induced insulitis and diabetes. Proc Natl Acad Sci U S A 74, 2485–2489.
23Maritim, AC, Sanders, RA & Watkins, JB (2003) Effects of α-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem 14, 288–294.
24Johnson, RN, Metcalf, PA & Baker, JR (1982) Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 127, 87–95.
25Ohkawa, H, Ohishi, N & Yagi, K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95, 351–358.
26Ellman, CL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82, 70–77.
27Lowry, OH, Rosebrough, NL, Farr, AL, et al. (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193, 265–275.
28Misra, HP & Fridovich, I (1972) The role of superoxide anion in the autooxidation of epinephrine and simple assay for superoxide dismutase. J Biol Chem 247, 3170–3175.
29Claiborne, A (1984) Catalase activity. In Handbook of Methods for Oxygen Radical Research, pp. 283–284 [Greenwald, RA, editor]. Boca Raton, FL: CRC Press, Inc.
30Albrektsen, T, Richter, HE, Clausen, JT, et al. (2001) Identification of a novel integral plasma membrane protein induced during adipocyte differentiation. Biochem J 359, 393–402.
31Jackson, SP & Tjian, R (1989) Purification and analysis of RNA polymerase II transcription factors by using wheat germ agglutinin affinity chromatography. Proc Natl Acad Sci U S A 86, 1781–1785.
32Laemmli, UK (1970) Cleavage of structural proteins during the assembly of heat of bacteriophage T4. Nature 227, 680–685.
33Towbin, H, Staehelin, T & Gordon, J (1979) Electrophoretic transfer of proteins from polyacrilamifostinede gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76, 4350–4354.
34Ossipow, V, Descombes, P & Schibler, U (1993) CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc Natl Acad Sci U S A 90, 8219–8223.
35Packer, L & Cadenas, E (2011) Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling. J Clin Biochem Nutr 48, 26–32.
36Hart, GW, Housley, MP & Slawson, C (2007) Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446, 1017–1022.
37Michael, MD, Kulkarni, RN, Postic, C, et al. (2000) Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6, 87–97.
38Mitra, V & Metcalf, J (2009) Metabolic functions of the liver. Anaesth Intens Care Med 10, 334–335.
39Zafar, M & Naqvi, SNH (2010) Effects of STZ-induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: a comparative study. Int J Morphol 28, 135–142.
40Godin, DV, Wohaieh, SA, Garnett, ME, et al. (1988) Antioxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem 84, 223–231.
41Limaye, PV, Raghuram, N & Sivakami, S (2003) Oxidative stress and gene expression of antioxidant enzymes in the renal cortex of streptozotocin-induced diabetic rats. Mol Cell Biochem 243, 147–152.
42Sadi, G, Yılmaz, Ö & Güray, T (2008) Effect of vitamin C and lipoic acid on streptozotocin-induced diabetes gene expression: mRNA and protein expressions of Cu–Zn SOD and catalase. Mol Cell Biochem 309, 109–116.
43Cardinal, JW, Margison, GP, Mynett, KJ, et al. (2001) Increased susceptibility to streptozotocin-induced beta cell apoptosis and delayed autoimmune diabetes in alkylpurine-DNA-N-glycosylase-deficient mice. Mol Cell Biol 21, 5605–5613.
44Özcan, S, Andrali, SS & Cantrell, JEL (2010) Modulation of transcription factor function by O-GlcNAc modification. Biochim Biophys Acta 1799, 353–364.
45Cao, C, Leng, Y & Kufe, D (2003) Catalase activity is regulated by c-Abl and Arg in the oxidative stress response. J Biol Chem 278, 29667–29675.
46Cao, C, Leng, Y, Liu, X, et al. (2003) Catalase is regulated by ubiquitination and proteosomal degradation. Role of the c-Abl and Arg tyrosine kinases. Biochemistry 42, 10348–10353.
47Liu, X, Huang, W, Li, C, et al. (2006) Interaction between c-Abl and Arg tyrosine kinases and proteasome subunit PSMA7 regulates proteasome degradation. Mol Cell 22, 317–327.
48Yamakura, F & Kawasaki, H (2010) Post-translational modifications of superoxide dismutase. Biochim Biophys Acta 1804, 318–325.
49Rechsteiner, M & Rogers, SW (1996) PEST sequences and regulation by proteolysis. Trends Biochem Sci 21, 267–271.
50Vermeulen, L, De Wilde, G, Van Damme, P, et al. (2003) Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 22, 1313–1324.
51Hu, J, Roy, SK, Shapiro, PS, et al. (2001) ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma. J Biol Chem 276, 287–297.
52Sen, KC & Packer, L (1996) Antioxidant and redox regulation of gene transcription. FASEB J 10, 709–720.
53King, GL (2008) The role of inflammatory cytokines in diabetes and its complications. J Periodontol 79, 1527–1534.
54Baker, RG, Hayden, MS & Ghosh, S (2011) NF-κB, inflammation, and metabolic disease. Cell Metab 13, 11–22.
55Rojo, AI, Salinas, M, Martin, D, et al. (2004) Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB. J Neurosci 24, 7324–7334.
56St Clair, DK, Porntadavity, S, Xu, Y, et al. (2002) Transcription regulation of human manganese superoxide dismutase gene. Method Enzymol 349, 306–312.
57Taniguchi, M, Hashimoto, M, Hori, N, et al. (2005) CCAAT/enhancer binding protein-β (C/EBP-β), a pivotal regulator of the TATA-less promoter in the rat catalase gene. FEBS Lett 579, 5785–5790.
58Seo, SJ, Kim, HT, Cho, G, et al. (1996) Sp1 and C/EBP-related factor regulate the transcription of human Cu/Zn SOD gene. Gene 178, 177–185.
59Seo, SJ, Kang, SS, Cho, G, et al. (1997) C/EBP alpha and C/EBPbeta play similar roles in the transcription of the human Cu/Zn SOD gene. Gene 203, 11–15.
60Kim, YH, Yoo, HY, Chang, MS, et al. (1997) C/EBP alpha is a major activator for the transcription of rat Cu/Zn superoxide dismutase gene in liver cell. FEBS Lett 401, 267–270.
61Qiu, X, Aiken, KJ, Chokas, AL, et al. (2008) Distinct functions of CCAAT enhancer-binding protein isoforms in the regulation of manganese superoxide dismutase during interleukin-1beta stimulation. J Biol Chem 283, 25774–25785.
62Yang, WH, Park, SY, Nam, HW, et al. (2008) NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc Natl Acad Sci U S A 105, 17345–17350.
63Bosch, F, Sabater, J & Valera, A (1995) Insulin inhibits liver expression of the CCAAT/enhancer-binding protein beta. Diabetes 44, 267–271.
64Arizmendi, C, Liu, S, Croniger, C, et al. (1999) The transcription factor CCAAT-enhancer binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J Biol Chem 274, 13033–13040.
65Singh, U & Jialal, I (2008) Alpha-lipoic acid supplementation and diabetes. Nutr Rev 66, 646–657.
66Ridruejo, E, Castiglioni, T & O Silva, M (2011) Thioctic acid-induced acute cholestatic hepatitis. Ann Pharmacother 45, e43.
67Wassmann, S, Wassmann, K & Nickenig, G (2004) Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 44, 381–386.